Bipolar Disorder
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
We investigated the relationship between cognitive performance and a deletion allele within GluK4 protective against risk for bipolar disorder, in 1,642 individuals from the TwinsUK study.
|
29243543 |
2019 |
Schizophrenia
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
These changes in glutamatergic activity reverse when Grik4 levels are normalized; thus, they may account for the behavioral abnormalities in disorders like autism or schizophrenia.
|
29949767 |
2018 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
GluK4 knockout mice also showed marked hyperactivity and impaired pre-pulse inhibition, thereby mirroring two of the hallmark endophenotypes of patients with schizophrenia and bipolar disorder.
|
23357115 |
2013 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
GluK4 knockout mice also showed marked hyperactivity and impaired pre-pulse inhibition, thereby mirroring two of the hallmark endophenotypes of patients with schizophrenia and bipolar disorder.
|
23357115 |
2013 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
These results support our hypothesis that the deletion allele affords protection against bipolar disorder through increased KA1 protein abundance in neuronal cells.
|
22052594 |
2012 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
BEFREE |
These results support our hypothesis that the deletion allele affords protection against bipolar disorder through increased KA1 protein abundance in neuronal cells.
|
22052594 |
2012 |
Bipolar Disorder
|
0.350 |
GeneticVariation
|
disease |
LHGDN |
A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder.
|
18824690 |
2008 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder.
|
18824690 |
2008 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
These results suggest that the five SNPs within the GRIK4 gene are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.
|
18289755 |
2008 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the five SNPs within the GRIK4 gene are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.
|
18289755 |
2008 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
This gene is disrupted by a translocation breakpoint in a patient with schizophrenia, and case control studies show significant association of GRIK4 with both schizophrenia and bipolar disorder.
|
17449450 |
2007 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
BEFREE |
This gene is disrupted by a translocation breakpoint in a patient with schizophrenia, and case control studies show significant association of GRIK4 with both schizophrenia and bipolar disorder.
|
17449450 |
2007 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
BEFREE |
This gene is disrupted by a translocation breakpoint in a patient with schizophrenia, and case control studies show significant association of GRIK4 with both schizophrenia and bipolar disorder.
|
17449450 |
2007 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
This gene is disrupted by a translocation breakpoint in a patient with schizophrenia, and case control studies show significant association of GRIK4 with both schizophrenia and bipolar disorder.
|
17449450 |
2007 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder.
|
16819533 |
2006 |
Bipolar Disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
This identified two discrete regions of disease risk within the GRIK4 locus: three single single nucleotide polymorphism (SNP) markers with a corresponding underlying haplotype associated with susceptibility to schizophrenia (P=0.0005, odds ratio (OR) of 1.453, 95% CI 1.182-1.787) and two single SNP markers and a haplotype associated with a protective effect against bipolar disorder (P=0.0002, OR of 0.624, 95% CI 0.485-0.802).
|
16819533 |
2006 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Here we report association studies of schizophrenia with polymorphisms in three kainate receptor genes: GRIK3, GRIK4 and GRIK5.
|
16325263 |
2006 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
LHGDN |
This identified two discrete regions of disease risk within the GRIK4 locus: three single single nucleotide polymorphism (SNP) markers with a corresponding underlying haplotype associated with susceptibility to schizophrenia (P=0.0005, odds ratio (OR) of 1.453, 95% CI 1.182-1.787) and two single SNP markers and a haplotype associated with a protective effect against bipolar disorder (P=0.0002, OR of 0.624, 95% CI 0.485-0.802).
|
16819533 |
2006 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
BEFREE |
Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia.
|
16325263 |
2006 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
This identified two discrete regions of disease risk within the GRIK4 locus: three single single nucleotide polymorphism (SNP) markers with a corresponding underlying haplotype associated with susceptibility to schizophrenia (P=0.0005, odds ratio (OR) of 1.453, 95% CI 1.182-1.787) and two single SNP markers and a haplotype associated with a protective effect against bipolar disorder (P=0.0002, OR of 0.624, 95% CI 0.485-0.802).
|
16819533 |
2006 |
Major Depressive Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Accumulated evidence implicates the involvement of glutamatergic receptors in the pathophysiology of MDD and antidepressant treatment.By using 193 MDD patients who have been taking venlafaxine for 6 weeks, we investigated whether single nucleotide polymorphisms (SNPs) in glutamate ionotropic receptor kainate type subunit 4 (GRIK4), glutamate ionotropic receptor AMPA type subunit 1 (GRIA1) and glutamate metabotropic receptor 7 (GRM7) were associated with treatment response.
|
31083176 |
2019 |
Major Depressive Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
In summary, our results firstly indicated that rs56275759 of GRIK4 gene might be associated with MDD in Chinese Han population.
|
28583584 |
2017 |
Major Depressive Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
|
22222462 |
2012 |
Major Depressive Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
|
22222462 |
2012 |
Unipolar Depression
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Common variants in GRIK4 and major depressive disorder: An association study in the Chinese Han population.
|
28583584 |
2017 |